PURPOSE: To simultaneously detect iron-labeled cancer cells and brain tumors in vivo in one scan, the balanced steady-state free precession (b-SSFP) imaging sequence was optimized at 1.5 T on mice developing brain metastases subsequent to the injection of micron-sized iron oxide particle-labeled human breast cancer cells. MATERIALS AND METHODS: b-SSFP sequence parameters (repetition time, flip angle, and receiver bandwidth) were varied and the signal-to-noise ratio, contrast between the brain and tumors, and the number of detected iron-labeled cells were evaluated. RESULTS: Optimal b-SSFP images were acquired with a 26 msec repetition time, 35° flip angle, and bandwidth of ±21 kHz. b-SSFP images were compared with T(2) -weighted 2D fast spin echo (FSE) and 3D spoiled gradient recalled echo (SPGR) images. The mean tumor-brain contrast-to-noise ratio and the ability to detect iron-labeled cells were the highest in the b-SSFP images. CONCLUSION: A single b-SSFP scan can be used to visualize both iron-labeled cells and brain metastases.
PURPOSE: To simultaneously detect iron-labeled cancer cells and brain tumors in vivo in one scan, the balanced steady-state free precession (b-SSFP) imaging sequence was optimized at 1.5 T on mice developing brain metastases subsequent to the injection of micron-sized iron oxide particle-labeled humanbreast cancer cells. MATERIALS AND METHODS: b-SSFP sequence parameters (repetition time, flip angle, and receiver bandwidth) were varied and the signal-to-noise ratio, contrast between the brain and tumors, and the number of detected iron-labeled cells were evaluated. RESULTS: Optimal b-SSFP images were acquired with a 26 msec repetition time, 35° flip angle, and bandwidth of ±21 kHz. b-SSFP images were compared with T(2) -weighted 2D fast spin echo (FSE) and 3D spoiled gradient recalled echo (SPGR) images. The mean tumor-brain contrast-to-noise ratio and the ability to detect iron-labeled cells were the highest in the b-SSFP images. CONCLUSION: A single b-SSFP scan can be used to visualize both iron-labeled cells and brain metastases.
Authors: Neal K Bangerter; Brian A Hargreaves; Shreyas S Vasanawala; John M Pauly; Garry E Gold; Dwight G Nishimura Journal: Magn Reson Med Date: 2004-05 Impact factor: 4.668
Authors: Soha Said Ramadan; Chris Heyn; Lisa T Mackenzie; Ann F Chambers; Brian K Rutt; Paula J Foster Journal: MAGMA Date: 2008-06-25 Impact factor: 2.310
Authors: Chris Heyn; John A Ronald; Lisa T Mackenzie; Ian C MacDonald; Ann F Chambers; Brian K Rutt; Paula J Foster Journal: Magn Reson Med Date: 2006-01 Impact factor: 4.668
Authors: Amanda M Hamilton; Sallouha Aidoudi-Ahmed; Shweta Sharma; Venkata R Kotamraju; Paula J Foster; Kazuki N Sugahara; Erkki Ruoslahti; Brian K Rutt Journal: J Mol Med (Berl) Date: 2015-04-14 Impact factor: 4.599
Authors: Mevan Perera; Emeline J Ribot; Dean B Percy; Catherine McFadden; Carmen Simedrea; Diane Palmieri; Ann F Chambers; Paula J Foster Journal: Transl Oncol Date: 2012-06-01 Impact factor: 4.243
Authors: Donna H Murrell; Amanda M Hamilton; Christiane L Mallett; Robbert van Gorkum; Ann F Chambers; Paula J Foster Journal: Transl Oncol Date: 2015-06 Impact factor: 4.243
Authors: Katie M Parkins; Amanda M Hamilton; Ashley V Makela; Yuanxin Chen; Paula J Foster; John A Ronald Journal: Sci Rep Date: 2016-10-21 Impact factor: 4.379
Authors: Alexandra Scharf; Shannon P Holmes; Merrilee Thoresen; Jennifer Mumaw; Alaina Stumpf; John Peroni Journal: Stem Cells Int Date: 2016-09-26 Impact factor: 5.443
Authors: Katie M Parkins; Veronica P Dubois; Amanda M Hamilton; Ashley V Makela; John A Ronald; Paula J Foster Journal: Sci Rep Date: 2018-06-12 Impact factor: 4.379